$2.82
0.3514.17%
In chiusura: -
$2.78
-0.04-1.42%
After hour: 5:11 PM EDT
ImmunityBio segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di ImmunityBio utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IBRX | ImmunityBio | -$0.14 | -$0.11 | — | — | $6.11M | $26.55M | — | — | 11/11/2025 | |
IBRX | ImmunityBio | -$0.20 | -$0.11 | -$0.10 | 0.00% | $1.05M | $21.49M | $26.43M | 5.74% | 08/05/2025 | |
IBRX | ImmunityBio | -$0.20 | -$0.13 | -$0.15 | -7.14% | $40.00K | $21.49M | $16.52M | -5.62% | 05/12/2025 | |
IBRX | ImmunityBio | -$0.38 | $0.08 | -$0.09 | 65.38% | $139.00K | $19.93M | $7.55M | -13.59% | 03/03/2025 | |
IBRX | ImmunityBio | -$0.19 | -$0.17 | -$0.14 | 17.65% | $82.00K | $6.16M | $6.11M | 40.05% | 11/12/2024 | |
IBRX | ImmunityBio | -$0.32 | -$0.16 | -$0.20 | -17.65% | $41.00K | $10.03M | $1.05M | -58.45% | 08/12/2024 | |
IBRX | ImmunityBio | -$0.27 | -$0.16 | -$0.20 | -25.00% | $360.00K | $20.00K | $40.00K | 100.00% | 05/09/2024 | |
IBRX | ImmunityBio | -$0.27 | -$0.18 | -$0.38 | -111.11% | $73.00K | $20.00K | $139.00K | 595.00% | 03/19/2024 | |
IBRX | ImmunityBio | -$0.28 | -$0.27 | -$0.19 | 29.63% | $118.00K | $30.00K | $82.00K | 173.33% | 11/09/2023 | |
IBRX | ImmunityBio | -$0.24 | -$0.23 | -$0.32 | -39.13% | $35.00K | — | $41.00K | — | 08/08/2023 | |
IBRX | ImmunityBio | -$0.26 | $0.00 | -$0.27 | -100.00% | $14.00K | $360.00K | $360.00K | 0.00% | 05/11/2023 | |
IBRX | ImmunityBio | -$0.23 | -$0.22 | -$0.27 | -22.73% | $390.00K | $30.00K | $73.00K | 143.33% | 03/01/2023 | |
IBRX | ImmunityBio | -$0.22 | — | -$0.22 | — | $66.00K | — | $118.00K | — | 11/09/2022 | |
IBRX | ImmunityBio | -$0.23 | — | -$0.24 | — | $339.00K | — | $35.00K | — | 08/08/2022 | |
IBRX | ImmunityBio | -$0.21 | — | -$0.26 | — | $139.00K | — | $14.00K | — | 05/10/2022 | |
IBRX | ImmunityBio | -$0.18 | — | -$0.23 | — | -$147.00K | — | $390.00K | — | 03/02/2022 | |
IBRX | ImmunityBio | -$0.17 | — | -$0.22 | — | $151.00K | — | $66.00K | — | 11/12/2021 | |
IBRX | ImmunityBio | — | — | -$0.23 | — | — | — | $339.00K | — | 08/12/2021 | |
IBRX | ImmunityBio | — | — | -$0.21 | — | — | — | $139.00K | — | 05/14/2021 | |
IBRX | ImmunityBio | — | — | -$0.89 | — | — | — | $111.00K | — | 03/04/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-05 | $-0.10 | $-0.11 | 0.00 % |
Q1 | 2025-05-12 | $-0.15 | $-0.13 | -7.14 % |
Q4 | 2025-03-03 | $-0.09 | $0.08 | 65.4 % |
Q3 | 2024-11-12 | $-0.14 | $-0.17 | 17.6 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-05 | $26.43M | $21.49M | 5.74 % |
Q1 | 2025-05-12 | $16.52M | $21.49M | -5.62 % |
Q4 | 2025-03-03 | $7.55M | $19.93M | -13.6 % |
Q3 | 2024-11-12 | $6.11M | $6.16M | 40.1 % |
Si prevede che ImmunityBio (IBRX) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
L'EPS effettivo era $-0.10, che superato la stima di $-0.11.
Le entrate effettive sono state $26.4M, che superato la stima di $21.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.